image

The best stocks to buy since 1993

Latest issue now available

Kape

October 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KAPE
  • Price:
  • 166.5p
Kape’s H1 shows sales increased 97% to US$59m. Adjusted EBITDA increased by 185% (22% on a proforma basis) to US$16.4m while the adjusted EBITDA margin increased to 27.8% (H1 2019: 19.2%). Adjusted EBITDA margins improved by 8.6% to 27.8% as the benefits of operational gearing kicked in.Subscriber numbers increased to 2.38m. Overall, Kape invested US$29.2m cash into direct marketing (US$11m more than last year) so the benefit of this comes next year. Kape ended the half year with US$25.6m net debt.Digital Privacy, which comprises three VPN brands (CyberGhost, PIA, ZenMate), saw revenues balloon by 277% to US$24.6m (78% of total). The period, of course, includes PIA for the first time and this contributed US$24.3m to sal ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe